Association between menopausal hormone therapy and incidence of psoriasis: a secondary analysis from the Women's Health Initiative randomized clinical trials
Br J Dermatol
.
2021 Sep;185(3):669-671.
doi: 10.1111/bjd.20410.
Epub 2021 Jun 14.
Authors
A A Chan
1
,
J Noguti
1
,
C T Yang
2
,
S R Feldman
3
,
R B Wallace
4
,
A H Shadyab
5
,
J E Manson
6
,
A K Aragaki
7
,
R T Chlebowski
8
,
D J Lee
1
Affiliations
1
Department of Medicine, Division of Dermatology, The Lundquist Institute, Torrance, CA, 90503, USA.
2
Boston University School of Medicine, Boston, MA, 02118, USA.
3
Wake Forest School of Medicine, Winston-Salem, NC, 27101, USA.
4
University of Iowa College of Public Health, Department of Epidemiology, Iowa City, IA, 52242, USA.
5
Department of Family Medicine and Public Health, University of California, San Diego School of Medicine, La Jolla, CA, 92093, USA.
6
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
7
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
8
Department of Medicine, Division of Hematology/Oncology, The Lundquist Institute, Torrance, CA, 90503, USA.
PMID:
33913153
DOI:
10.1111/bjd.20410
No abstract available
Publication types
Letter
MeSH terms
Female
Humans
Incidence
Menopause
Psoriasis* / chemically induced
Psoriasis* / drug therapy
Psoriasis* / epidemiology
Randomized Controlled Trials as Topic
Women's Health*